Copyright Licensing Agency Licence Certificate 2023-24

This is to certify that The Copyright Licensing Agency Limited (“CLA”) has granted a Licence...

View document

MHRA Phase I Accreditation Certificate (October 2023)

The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.

View document

MHRA Phase I Accreditation Certificate (01 June 2022)

The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.

View document

MHRA Phase I Accreditation Certificate (August 2020)

MHRA Phase I Accreditation Certificate (August 2020)

View document

MHRA Phase I Accreditation Certificate (April 2017)

MHRA Phase I Accreditation Certificate (April 2017)

View document

MHRA Phase I Accreditation Certificate (March 2015)

MHRA Phase I Accreditation Certificate (March 2015)

View document

MHRA Phase I Accreditation Certificate (March 2013)

MHRA Phase I Accreditation Certificate (March 2013)

View document

Corporate Accounts 2021

Corporate Accounts 2021

View document

Corporate Accounts 2020

Corporate Accounts 2020

View document

Corporate Accounts 2019

Corporate Accounts 2019

View document

Corporate Accounts 2018

Corporate Accounts 2018

View document

Latest news

Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy

September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event